
Kevan Shokat
Kevan Shokat is a professor at the University of California and a co-founder of Revolution Medicines, credited with developing a novel method to block proteins that drive cancer cell growth, leading to innovative therapies targeting RAS mutations.
Power618
Reach7,645
Country presence
Recent news mentions
Kevan Shokat is a biochemist from the University of California, San Francisco, who expressed surprise at the breakthrough of the new drug Daraxonrasib.
Durchbruch mit neuem Medikament DaraxonrasibNeue Zürcher Zeitung·
Switzerland· 2026-07-21
Kevan Shokat developed a new method to block a protein that sends signals to cancer cells to grow.
Πειραματικό χάπι γεννά ελπίδες για έναν από τους πιο θανατηφόρους καρκίνουςKathimerini·
Greece· 2025-11-06










